NICOLO', MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 6.080
Totale 6.080
Nazione #
IT - Italia 6.080
Totale 6.080
Città #
Genova 4.231
Rapallo 707
Genoa 620
Vado Ligure 491
Bordighera 31
Totale 6.080
Nome #
Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy. 155
Pleomorphic adenocarcinoma of the ciliary epithelium: a clinicopathological, immunohistochemical, ultrastructural, DNA-ploidy and comparative genomic hybridization analysis of an unusual case. 152
I-Maculaweb: A Tool to Support Data Reuse in Ophthalmology 151
Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin 133
Yellow micropulse laser in diabetic macular edema: a short-term pilot study. 132
Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin 131
Choroidal metastasis from a cutaneous malignant melanoma regressed after cisplatin therapy. 124
Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach. 124
Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration. 119
Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform 115
Marker gene transfer and oncolysis of human Y79 retinoblastoma cells mediated by herpes simplex virus mutants. 114
Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy 114
Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). 113
Follicular large-cell lymphoma of the orbit: a clinicopathologic, immunohistochemical and molecular genetic description of one case. 113
Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography 112
Chorioretinal folds: a proposed diagnostic algorithm 112
Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes. 111
Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. 108
Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunit. 108
Eales Disease Associated with Serpiginous Choroiditis 108
Early swept-source optical coherence tomography angiography findings in unilateral acute idiopathic maculopathy 107
Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series. 105
Response to anti-VEGF-A treatment of retinal pigment epithelial cells in vitro. 105
Response to anti-VEGF-A treatment of endothelial cells in vitro 102
Morphological, physiological, and biochemical changes in rhodopsin knockout mice. 102
Detection of tenascin-C in surgically excised choroidal neovascular membranes. 100
Silent occult choroidal vascular abnormalities. 100
Choroidal hemangioma treated with photodynamic therapy using verteporfin: report of a case. 95
Inhibition of a vascular ocular tumor growth by IL-12 gene transfer. 94
A Web-tool to manage ophtalmologic electronic health record 94
Re: Evaluation of choroidal changes in adolescent idiopathic scoliosis using enhanced depth imaging optical coherence tomography 94
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 94
Allograftreaction after penetrating keratoplasty 93
Chorioretinal folds: associated disorders and a related maculopathy. 90
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 89
The Effects of Ocular Perfusion Pressure Variations on a Case of Circumscribed Choroidal Hemangioma Affected by Primary Open-Angle Glaucoma 87
Diagnostic and Therapeutic Challanges 86
Choroidal vascular reactivity in central serous chorioretinopathy 85
Real-life data in the treatment of neovascular age-related macular degeneration. Results from the I-maculaweb registry evaluated in a single Italian Medical Retina center. 82
Subthreshold laser grid photocoagulation for the treatment of diabetic macular edema 80
Reply 79
Real-Life Management of Diabetic Macular Edema with Dexamethasone Intravitreal Implant: A Retrospective Analysis of Long-Term Clinical Outcomes 78
Multiple bilateral choroidal metastatic tumors from a small-cell neuroendocrine carcinoma of unknown primary site. 77
Retinal vascular reactivity in central serous chorioretinopathy 77
Solitary fibrous tumor of the inguinal region: a clinicopathological, light-microscopic, immunohistochemical, electron microscopic and flow-cytometric DNA study. 75
Malignant melanoma of soft tissues (clear cell sarcoma) of the foot. Is MRI able to perform a specific diagnosis? Report of one case and review of the radiological literature. 74
Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT 71
Photodynamic Therapy of Rabbit Corneal Neoascularization with Photosensitizer Conjugated to Antibody against the Extradomain–B of Fibronectin 69
Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization 66
Photodynamic Therapy of Choroidal Neovascularization Using Verteporfin in Pathologic Myopia: Analysis of Visual Outcomes 63
Choroidal Melanoma treatment with proton beam: first nine years of experience of the Genoa Ocular Oncology Group 62
Vascular Density and Retinal Function in patients with Retinitis Pigmentosa evaluated by swept-source OCT angiography and microperimetry 60
Occhioallaretina.it 58
"Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients" 57
La cheratotomia radiale per la riduzione della miopia inferiore alle 3 diottrie. 50
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview 46
Teprotumumab. Anti-insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, Treatment of thyroid eye disease 45
Gli impianti drenanti per la terapia dei glaucomi refrattari 43
Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration 43
Ocular biometric parameters changes and choroidal vascular abnormalities in patients with neurofibromatosis type 1 evaluated by OCT-A 43
Risuteganib. Broad-spectrum integrin inhibitor, Treatment of diabetic macular edema, Treatment of dry age-related macular degeneration 42
Effects of the hand-grip test on retinal vascular and structural parameters measured by optical coherence tomography in healthy subjects 42
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series 40
Correspondence. 39
Efficacy of a New Commercial Ocular Spray Containing Oftasecur Citrus Extract for Reducing Microbial Load in the Conjunctiva of Patients Receiving Intravitreal Injections 39
Bilateral choroidal detachment and myopic shift after acetazolamide intake for laser capsulotomy 38
Inhibitory action of antidiabetic drugs on the free radical production by the rod outer segment ectopic aerobic metabolism 32
Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases 31
Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure 25
Retinal Pigment Epithelium Tear after Glaucoma Surgery 24
Razumab-the role of biosimilars for the treatment of retinal diseases 23
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography 21
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 21
The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases 20
Choroidal changes in intermediate age-related macular degeneration patients with drusen or pseudodrusen 19
An update on conbercept to treat wet age-related macular degeneration 18
Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis 17
Early DMO: a predictor of poor outcomes following cataract surgery in diabetic patients. The DICAT-II study 17
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak 17
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMD 16
Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation 14
MiR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells 13
Current pharmacological treatment options for central serous chorioretinopathy: A review 13
Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy 11
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases 9
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts 7
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 6
Autonomous artificial intelligence versus teleophthalmology for diabetic retinopathy 5
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials 5
PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration 5
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials 5
Reply [4] 5
Totale 6.208
Categoria #
all - tutte 22.488
article - articoli 21.806
book - libri 0
conference - conferenze 532
curatela - curatele 0
other - altro 150
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.235 0 0 0 0 120 148 227 105 131 252 184 68
2020/2021562 39 64 80 39 30 35 26 55 37 82 37 38
2021/2022776 18 60 63 62 30 43 45 181 55 73 41 105
2022/2023859 76 58 18 78 120 152 20 70 134 11 105 17
2023/2024513 18 82 14 73 41 78 15 54 25 14 18 81
2024/2025535 86 136 72 102 139 0 0 0 0 0 0 0
Totale 6.208